Recommendation : reclassify tumors by malignant pleural
or pericardial effusion as m1 disease.
c ) n descriptors subcommittee 28
this subcommittee studied the prognostic significance of
the nodal categories within the 6th edition and located that the current
n0 to n3 descriptors defined distinct prognostic groups
for each clinical and pathologic staging. they undertook exploratory
analyses on the prognostic impact of individual
nodal stations within the hilum and mediastinum, and combinations
and permutations of cell type, lobe of the primary, patterns
of nodal involvement in n1 and n2 locations, and therefore the
impact of “skip” metastases to the mediastinal nodes without
hilar node disease. though these analyses showed a few interesting
results, the teams were little and compromised geographically
and by treatment modality. they concluded that
any prospective studies were necessary before taking these
suggestions forward. such studies would be facilitated by an
agreed set of international definitions for nodal stations, and
a
brand new “iaslc” international nodal chart, that, for the primary
time, might reconcile the differences between the japanese
nodal chart and therefore the mountain/dressler chart. the concept of
“nodal zones” was prompt, amalgamating nodal stations into
larger units among the anatomical region. it had been hoped that
this would ensure that nodal mapping was relevant to oncologists
and radiologists used to handling bulky disease that
usually transgressed the boundaries of adjacent nodal stations.
recommendation : the existing categories of n0 to n3
ought to be retained for the 7th edition. an iaslc nodal chart
was created, incorporating the concept of nodal zones. 29
d ) m descriptors subcommittee 30
an analysis of these cases prompt for reclassification as
m1 caused by malignant pleural effusion showed the same survival
to those classified as m1 within the 6th edition due to
extra tumor nodules within the contralateral lung. these two
teams had a stronger survival than that of cases classified within the
6th edition as m1 by the presence of distant metastases, by a
little however significant distinction.
recommendation : reclassify m1 due to additional
tumor nodules within the contralateral lung as m1a. reclassify t4
tumors caused by malignant pleural or pericardial effusions
as m1a. reclassify m1 caused by distant metastatic disease
as m1b.
e ) changes to the tnm stage groupings within the 7th
edition 31
this aspect of the project raised problems that affected the
means that the recommendations derived from the t, n, and m
descriptor subcommittees were presented in the ultimate documents.
where analysis prompt that new descriptors were
necessary to accommodate patients whose prognosis differed
from the opposite cases among any explicit t or m class,
2 different strategies were thought of : ( a ) retain that descriptor
within the existing class, identified by alphabetical subsets.
as an example, extra pulmonary nodules within the lobe
of the primary, thought of to be t4 within the 6th edition, would
stay t4 however identified as t4a, whereas extra pulmonary
nodules in alternative ipsilateral lobes, designated as m1 in
the 6th edition, would become m1a. ( b ) enable descriptors to
move between categories, to a class containing alternative descriptors
with the same prognosis, as an example, extra pulmonary
nodules within the lobe of the primary would move from
t4 to t3, and extra pulmonary nodules in alternative ipsilateral
lobes would move from m1 to t4. the primary strategy had
the advantage of allowing, to an outsized extent, retrograde compatibility
with existing databases. unfortunately, this strategy
generated an outsized range of descriptors ( approximately twenty )
and an impractically massive range of tnm subsets ( 180 ).
for this reason, backward compatibility was compromised
and strategy b was preferred for its clinical utility. the recommendations
were so formatted as previously described.
these changes to t and m descriptors were then incorporated
into the resultant tnm subsets. atiny low range of candidate
stage grouping schemes were developed initially, based mostly on a
“training” set, employing a recursive partitioning and amalgamation
( rpa ) algorithm. 32 this generated a tree-based model
for the survival information using log-rank take a look at statistics for recursive
partitioning and, for choice of the necessary groupings,
bootstrap resampling to correct for the adaptive nature of the
splitting algorithm. an ordered list of groupings from the terminal
nodes of the “survival tree” was created, and with this
as a guide, many proposed stage groupings were created by
combining adjacent teams. choice of a final stage grouping
proposal from among the candidate schemes was based mostly on
its statistical properties within the coaching set and that its relevance to
clinical follow, and was arrived at by consensus.
the survival of cases among our database stratified by the
6th edition of tnm classification of malignant tumours and
by the iaslc proposals for the 7th edition are shown for cases
staged clinically in figure thirty. three and for pathologically staged
cases in figure thirty. four. the proposed system higher delineated
the first stage cases, where issues with overlap between
ib and that iia are noted with the 6th edition of tnm
classification of malignant tumours. thirty three improvement was also
seen within the distinction between clinical iia and that iib, furthermore as
the proportion of cases assigned to stage iia, another weakness
of the 6th edition of tnm classification of malignant
tumours. for each the clinical and pathological stage models,
there was a rise within the price for r two, an estimate of the
% variance explained ( pve ) by the model. thirty four the proposals
for the 7th edition created use of well-justified changes
to t and m, and served to determine subsets of patients with tumors
of totally different sizes with differing prognoses. each the proposed
new system and therefore the 6th edition of tnm classification
of malignant tumours showed a reversal on pathological staging
from the expected survival for advanced stage disease ( iiib
and that iv ). this result, though anomalous, may be explained
by the selective nature of advanced cases undergoing dissection,
several of that were taken to dissection on the assessment that
their disease was limited just to be discovered to own advanced
disease at thoracotomy.
Jumat, 27 Juli 2012
Langganan:
Posting Komentar (Atom)
0 komentar:
Posting Komentar